Medicare Program; Public Meeting in Calendar Year 2009 for New Clinical Laboratory Tests Payment Determinations, 24017-24019 [E9-12030]
Download as PDF
Federal Register / Vol. 74, No. 98 / Friday, May 22, 2009 / Notices
to the facility’s plan of correction in
a timely manner.
—CHAP’s capacity to provide us with
electronic data and reports necessary
for effective validation and
assessment of the organization’s
survey process.
—The adequacy of CHAP’s staff and
other resources, and its financial
viability.
—CHAP’s capacity to adequately fund
required surveys.
—CHAP’s policies with respect to
whether surveys are announced or
unannounced, to assure that surveys
are unannounced.
—CHAP’s agreement to provide us with
a copy of the most current
accreditation survey together with any
other information related to the
survey as we may require (including
corrective action plans).
IV. Response to Public Comments and
Notice Upon Completion of Evaluation
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Upon completion of our evaluation,
including evaluation of comments
received as a result of this notice, we
will publish a final notice in the Federal
Register announcing the result of our
evaluation.
V. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
erowe on PROD1PC63 with NOTICES
(Catalog of Federal Domestic Assistance
Program No. 93.778, Medical Assistance
Program; No. 93.773 Medicare—Hospital
Insurance Program; and No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: May 14, 2009.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. E9–12031 Filed 5–21–09; 8:45 am]
BILLING CODE 4120–01–P
VerDate Nov<24>2008
14:18 May 21, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1407–N]
Medicare Program; Public Meeting in
Calendar Year 2009 for New Clinical
Laboratory Tests Payment
Determinations
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
SUMMARY: This notice announces a
public meeting to receive comments and
recommendations (and data on which
recommendations are based) from the
public on the appropriate basis for
establishing payment amounts for a
specified list of new Clinical Procedural
Terminology (CPT) codes for clinical
laboratory tests in calendar year (CY)
2010. The meeting provides a forum for
interested parties to make oral
presentations and submit written
comments on the new codes that will be
included in Medicare’s Clinical
Laboratory Fee Schedule for CY 2010,
which will be effective on January 1,
2010. The development of the codes for
clinical laboratory tests is largely
performed by the CPT Editorial Panel
and will not be further discussed at the
Centers for Medicare & Medicaid
Services (CMS) meeting.
DATES: Meeting Date: The public
meeting is scheduled for Tuesday, July
14, 2009 from 9 a.m. to 2 p.m., Eastern
Standard Time (E.S.T.).
Deadline for Registration of
Presenters: All presenters for the public
meeting must register by July 9, 2009.
Deadline for Submitting Requests for
Special Accommodations: Requests for
special accommodations must be
received no later than 5 p.m., E.S.T. on
July 9, 2009, the final day of
registration.
Deadline for Submission of Written
Comments: Interested parties may
submit written comments on the
proposed payment determinations by
September 18, 2009, to the address
specified in the ADDRESSES section of
this notice.
ADDRESSES: The public meeting will be
held in the main auditorium of the
central building of the Centers for
Medicare & Medicaid Services (CMS),
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
FOR FURTHER INFORMATION CONTACT:
Glenn McGuirk, (410) 786–5723.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
24017
I. Background
Section 531(b) of the Medicare,
Medicaid, and SCHIP Benefits
Improvement and Protection Act of
2000 (BIPA) (Pub. L. 106–554) required
the Secretary to establish procedures for
coding and payment determinations for
new clinical diagnostic laboratory tests
under Part B of title XVIII of the Social
Security Act (the Act) that permit public
consultation in a manner consistent
with the procedures established for
implementing coding modifications for
International Classification of Diseases
(ICD–9–CM). The procedures and public
meeting announced in this notice for
new clinical laboratory tests are in
accordance with the procedures
published on November 23, 2001 in the
Federal Register (66 FR 58743) to
implement section 531(b) of BIPA.
Section 942(b) of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) added section 1833(h)(8)(B)
of the Act, which sets forth the methods
for determining payment bases for new
tests. Section 1833(h)(8)(A) of the Act
states that new tests are any clinical
diagnostic laboratory tests with respect
to which a new or substantially revised
health care common procedures code
(HCPCS) is assigned on or after January
1, 2005 (hereinafter referred to as, ‘‘new
test’’ or ‘‘new clinical laboratory test’’).
Pertinent to this notice, section
1833(h)(8)(B)(i) and (ii) of the Act
requires the Secretary to make available
to the public a list that includes new
tests for which establishment of a
payment amount is being considered for
a year and, on the same day that the list
is made available, to publish in the
Federal Register a notice of a meeting
to receive comments and
recommendations (and data on which
recommendations are based) from the
public on the appropriate basis for
establishing payment amounts for new
tests. Section 1833(h)(8)(B)(iii) of the
Act requires that we convene a public
meeting not less than 30 days after
publication of the notice in the Federal
Register. These requirements are
codified at 42 CFR part 414, subpart G.
A newly created Current Procedural
Terminology (CPT) code can either
represent a refinement or modification
of existing test methods, or a
substantially new test method. The
preliminary list of newly created CPT
codes for calendar year (CY) 2010 will
be published on our Web site at
https://www.cms.hhs.gov/
ClinicalLabFeeSched when this notice is
published in the Federal Register.
Two methods are used to establish
payment amounts for new tests
E:\FR\FM\22MYN1.SGM
22MYN1
24018
Federal Register / Vol. 74, No. 98 / Friday, May 22, 2009 / Notices
erowe on PROD1PC63 with NOTICES
included in the CY 2010 Clinical
Laboratory Fee Schedule. The first
method, called cross-walking, is used
when a new test is determined to be
comparable to an existing test, multiple
existing test codes, or a portion of an
existing test code. The new test code is
then assigned the related existing local
fee schedule amounts and the related
existing national limitation amount.
Payment for the new test is made at the
lesser of the local fee schedule amount
or the national limitation amount.
The second method, called gap-filling,
is used when no comparable existing
test is available. When using this
method, instructions are provided to
each Medicare carrier or Part A and Part
B Medicare Administrative Contractor
(MAC) to determine a payment amount
for its geographic area(s) for use in the
first year. These determinations are
based on the following sources of
information, if available: Charges for the
test and routine discounts to charges;
resources required to perform the test;
payment amounts determined by other
payers; and charges, payment amounts,
and resources required for other tests
that may be comparable or otherwise
relevant. The carrier-specific amounts
are used to establish a national
limitation amount for the following
years. For each new clinical laboratory
test code, a determination must be made
to either cross-walk or gap-fill.
II. Format
This meeting is open to the public.
The on-site check-in for visitors will be
held from 8:30 a.m., E.S.T. to 9 a.m.,
E.S.T., followed by opening remarks.
Registered persons from the public may
discuss and recommend payment
determinations for specific new test
codes for the CY 2010 Clinical
Laboratory Fee Schedule.
Oral presentations must be brief and
must be accompanied by three written
copies. Presenters may also make copies
available for approximately 50 meeting
participants. Presenters should address
the following:
• New test code(s) and descriptor.
• Test purpose and method.
• Costs.
• Charges.
• Make a recommendation with
rationale for one of two methods (crosswalking or gap-fill) for determining
payment for new tests.
Additionally, the presenters should
provide the data on which their
recommendations are based.
Presentations that do not address the
above five items may be considered
incomplete and may not be considered
by CMS when making a payment
determination. CMS may request
VerDate Nov<24>2008
14:18 May 21, 2009
Jkt 217001
missing information following the
meeting in order to prevent a
recommendation from being considered
incomplete.
A summary of the proposed new test
codes and the payment
recommendations that are presented
during the public meeting will be
posted on our Web site by early
September 2009 and can be accessed at
https://www.cms.hhs.gov/
ClinicalLabFeeSched.
In addition, the summary will list
other comments received by July 29,
2009 (15 days after the meeting). The
summary will also display our proposed
payment determinations, an explanation
of the reasons for each determination,
and the data on which the
determinations are based. Interested
parties may submit written comments
on the proposed payment
determinations by September 18, 2009,
to the address specified in the
ADDRESSES section of this notice. Final
payment determinations will be posted
on our Web site in October 2009. Each
determination will include a rationale,
data on which the determination is
based, and responses to comments and
suggestions received from the public.
After the final payment
determinations have been posted on our
Web site, the public may request
reconsideration of the payment
determinations as set forth in 42 CFR
414.509. See also (72 FR 66275 through
66280).
III. Registration Instructions
The Division of Ambulatory Services
in CMS is coordinating the public
meeting registration. Beginning June 15,
2009, registration may be completed online at the following Web address:
https://www.cms.hhs.gov/
ClinicalLabFeeSched. The following
information must be submitted when
registering:
• Name.
• Company name.
• Address.
• Telephone number(s).
• E-mail address(es).
When registering, individuals who
want to make a presentation must also
specify on which new clinical
laboratory test code(s) they will be
presenting comments. A confirmation
will be sent upon receipt of the
registration. Individuals must register by
the date specified in the DATES section
of this notice.
IV. Security, Building, and Parking
Guidelines
The meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
planning your arrival time, we
recommend allowing additional time to
clear security. It is suggested that you
arrive at the CMS facility between 8:15
a.m and 8:30 a.m., E.S.T. so that you
will be able to arrive promptly at the
meeting by 9 a.m., E.S.T. Individuals
who are not registered in advance will
not be permitted to enter the building
and will be unable to attend the
meeting. The public may not enter the
building earlier than 8:15 a.m., E.S.T.
(45 minutes before the convening of the
meeting).
Security measures include the
following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel. Persons without
proper identification may be denied
access to the building.
• Interior and exterior inspection of
vehicles (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Passing through a metal detector
and inspection of items brought into the
building. We note that all items brought
to CMS, whether personal or for the
purpose of demonstration or to support
a demonstration, are subject to
inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
V. Special Accommodations
Individuals attending the meeting
who are hearing or visually impaired
and have special requirements, or a
condition that requires special
assistance, should provide the
information upon registering for the
meeting. The deadline for registration is
listed in the DATES section of this notice.
VI. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
E:\FR\FM\22MYN1.SGM
22MYN1
Federal Register / Vol. 74, No. 98 / Friday, May 22, 2009 / Notices
Dated: May 14, 2009.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. E9–12030 Filed 5–21–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures
Reviews, Advisory Board on Radiation
and Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
erowe on PROD1PC63 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10 a.m.–5 p.m., June 9,
2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without a
public oral comment period. To access by
conference call dial the following
information 1 (866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
VerDate Nov<24>2008
14:18 May 21, 2009
Jkt 217001
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
whether there is reasonable likelihood that
such radiation doses may have endangered
the health of members of this class. The
Subcommittee on Procedures Reviews was
established to aid the Advisory Board in
carrying out its duty to advise the Secretary,
HHS, on dose reconstruction. It will be
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Office of Compensation Analysis
and Support (OCAS) and its dose
reconstruction contractor.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes: a
discussion of proposed new versions of the
computer-assisted telephone interview
scripts and procedures NIOSH uses to
interview claimants at the outset of the dose
reconstruction process; the disposition of
site-specific procedures; and, a continuation
of the comment-resolution process for other
dose reconstruction procedures under review
by the Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public, but
without a public comment period. In the
event an individual wishes to provide
comments, written comments may be
submitted. Any written comments received
will be provided at the meeting and should
be submitted to the contact person below in
advance of the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta GA 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 14, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–11990 Filed 5–21–09; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
24019
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control, Special
Emphasis Panel (SEP): Prevention of
Health Risk Behaviors Among Youth
With Attention-Deficit/Hyperactivity
Disorder (U01), FOA DD09–004
Notice of Cancellation: This notice
was published in the Federal Register
on April 30, 2009, Volume 74, Number
82, pages 19970–19971. The meeting
originally scheduled to convene on May
15, 2009 has been cancelled. The
meeting will be re-scheduled at a future
date, to be announced.
Contact Person for More Information:
Brenda Colley-Gilbert, Designated
Federal Officer, CDC, 4770 Buford
Highway, NE., Mailstop K92, Atlanta,
GA 30341, Telephone: (770) 488–6295.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 15, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–11994 Filed 5–21–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7014–N]
Medicare Program; Meeting of the
Advisory Panel on Medicare
Education, July 8, 2009
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
SUMMARY: This notice announces a
meeting of the Advisory Panel on
Medicare Education (the Panel) in
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of Health and Human Services
and the Administrator of the Centers for
Medicare & Medicaid Services on
opportunities to enhance the
effectiveness of consumer education
E:\FR\FM\22MYN1.SGM
22MYN1
Agencies
[Federal Register Volume 74, Number 98 (Friday, May 22, 2009)]
[Notices]
[Pages 24017-24019]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12030]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1407-N]
Medicare Program; Public Meeting in Calendar Year 2009 for New
Clinical Laboratory Tests Payment Determinations
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting to receive comments and
recommendations (and data on which recommendations are based) from the
public on the appropriate basis for establishing payment amounts for a
specified list of new Clinical Procedural Terminology (CPT) codes for
clinical laboratory tests in calendar year (CY) 2010. The meeting
provides a forum for interested parties to make oral presentations and
submit written comments on the new codes that will be included in
Medicare's Clinical Laboratory Fee Schedule for CY 2010, which will be
effective on January 1, 2010. The development of the codes for clinical
laboratory tests is largely performed by the CPT Editorial Panel and
will not be further discussed at the Centers for Medicare & Medicaid
Services (CMS) meeting.
DATES: Meeting Date: The public meeting is scheduled for Tuesday, July
14, 2009 from 9 a.m. to 2 p.m., Eastern Standard Time (E.S.T.).
Deadline for Registration of Presenters: All presenters for the
public meeting must register by July 9, 2009.
Deadline for Submitting Requests for Special Accommodations:
Requests for special accommodations must be received no later than 5
p.m., E.S.T. on July 9, 2009, the final day of registration.
Deadline for Submission of Written Comments: Interested parties may
submit written comments on the proposed payment determinations by
September 18, 2009, to the address specified in the ADDRESSES section
of this notice.
ADDRESSES: The public meeting will be held in the main auditorium of
the central building of the Centers for Medicare & Medicaid Services
(CMS), 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
FOR FURTHER INFORMATION CONTACT: Glenn McGuirk, (410) 786-5723.
SUPPLEMENTARY INFORMATION:
I. Background
Section 531(b) of the Medicare, Medicaid, and SCHIP Benefits
Improvement and Protection Act of 2000 (BIPA) (Pub. L. 106-554)
required the Secretary to establish procedures for coding and payment
determinations for new clinical diagnostic laboratory tests under Part
B of title XVIII of the Social Security Act (the Act) that permit
public consultation in a manner consistent with the procedures
established for implementing coding modifications for International
Classification of Diseases (ICD-9-CM). The procedures and public
meeting announced in this notice for new clinical laboratory tests are
in accordance with the procedures published on November 23, 2001 in the
Federal Register (66 FR 58743) to implement section 531(b) of BIPA.
Section 942(b) of the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub. L. 108-173) added section
1833(h)(8)(B) of the Act, which sets forth the methods for determining
payment bases for new tests. Section 1833(h)(8)(A) of the Act states
that new tests are any clinical diagnostic laboratory tests with
respect to which a new or substantially revised health care common
procedures code (HCPCS) is assigned on or after January 1, 2005
(hereinafter referred to as, ``new test'' or ``new clinical laboratory
test''). Pertinent to this notice, section 1833(h)(8)(B)(i) and (ii) of
the Act requires the Secretary to make available to the public a list
that includes new tests for which establishment of a payment amount is
being considered for a year and, on the same day that the list is made
available, to publish in the Federal Register a notice of a meeting to
receive comments and recommendations (and data on which recommendations
are based) from the public on the appropriate basis for establishing
payment amounts for new tests. Section 1833(h)(8)(B)(iii) of the Act
requires that we convene a public meeting not less than 30 days after
publication of the notice in the Federal Register. These requirements
are codified at 42 CFR part 414, subpart G.
A newly created Current Procedural Terminology (CPT) code can
either represent a refinement or modification of existing test methods,
or a substantially new test method. The preliminary list of newly
created CPT codes for calendar year (CY) 2010 will be published on our
Web site at https://www.cms.hhs.gov/ClinicalLabFeeSched when this notice
is published in the Federal Register.
Two methods are used to establish payment amounts for new tests
[[Page 24018]]
included in the CY 2010 Clinical Laboratory Fee Schedule. The first
method, called cross-walking, is used when a new test is determined to
be comparable to an existing test, multiple existing test codes, or a
portion of an existing test code. The new test code is then assigned
the related existing local fee schedule amounts and the related
existing national limitation amount. Payment for the new test is made
at the lesser of the local fee schedule amount or the national
limitation amount.
The second method, called gap-filling, is used when no comparable
existing test is available. When using this method, instructions are
provided to each Medicare carrier or Part A and Part B Medicare
Administrative Contractor (MAC) to determine a payment amount for its
geographic area(s) for use in the first year. These determinations are
based on the following sources of information, if available: Charges
for the test and routine discounts to charges; resources required to
perform the test; payment amounts determined by other payers; and
charges, payment amounts, and resources required for other tests that
may be comparable or otherwise relevant. The carrier-specific amounts
are used to establish a national limitation amount for the following
years. For each new clinical laboratory test code, a determination must
be made to either cross-walk or gap-fill.
II. Format
This meeting is open to the public. The on-site check-in for
visitors will be held from 8:30 a.m., E.S.T. to 9 a.m., E.S.T.,
followed by opening remarks. Registered persons from the public may
discuss and recommend payment determinations for specific new test
codes for the CY 2010 Clinical Laboratory Fee Schedule.
Oral presentations must be brief and must be accompanied by three
written copies. Presenters may also make copies available for
approximately 50 meeting participants. Presenters should address the
following:
New test code(s) and descriptor.
Test purpose and method.
Costs.
Charges.
Make a recommendation with rationale for one of two
methods (cross-walking or gap-fill) for determining payment for new
tests.
Additionally, the presenters should provide the data on which their
recommendations are based. Presentations that do not address the above
five items may be considered incomplete and may not be considered by
CMS when making a payment determination. CMS may request missing
information following the meeting in order to prevent a recommendation
from being considered incomplete.
A summary of the proposed new test codes and the payment
recommendations that are presented during the public meeting will be
posted on our Web site by early September 2009 and can be accessed at
https://www.cms.hhs.gov/ClinicalLabFeeSched.
In addition, the summary will list other comments received by July
29, 2009 (15 days after the meeting). The summary will also display our
proposed payment determinations, an explanation of the reasons for each
determination, and the data on which the determinations are based.
Interested parties may submit written comments on the proposed payment
determinations by September 18, 2009, to the address specified in the
ADDRESSES section of this notice. Final payment determinations will be
posted on our Web site in October 2009. Each determination will include
a rationale, data on which the determination is based, and responses to
comments and suggestions received from the public.
After the final payment determinations have been posted on our Web
site, the public may request reconsideration of the payment
determinations as set forth in 42 CFR 414.509. See also (72 FR 66275
through 66280).
III. Registration Instructions
The Division of Ambulatory Services in CMS is coordinating the
public meeting registration. Beginning June 15, 2009, registration may
be completed on-line at the following Web address: https://www.cms.hhs.gov/ClinicalLabFeeSched. The following information must be
submitted when registering:
Name.
Company name.
Address.
Telephone number(s).
E-mail address(es).
When registering, individuals who want to make a presentation must
also specify on which new clinical laboratory test code(s) they will be
presenting comments. A confirmation will be sent upon receipt of the
registration. Individuals must register by the date specified in the
DATES section of this notice.
IV. Security, Building, and Parking Guidelines
The meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival time, we recommend allowing additional time to clear security.
It is suggested that you arrive at the CMS facility between 8:15 a.m
and 8:30 a.m., E.S.T. so that you will be able to arrive promptly at
the meeting by 9 a.m., E.S.T. Individuals who are not registered in
advance will not be permitted to enter the building and will be unable
to attend the meeting. The public may not enter the building earlier
than 8:15 a.m., E.S.T. (45 minutes before the convening of the
meeting).
Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel. Persons without proper identification may be denied access
to the building.
Interior and exterior inspection of vehicles (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Passing through a metal detector and inspection of items
brought into the building. We note that all items brought to CMS,
whether personal or for the purpose of demonstration or to support a
demonstration, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for demonstration or to support a demonstration.
V. Special Accommodations
Individuals attending the meeting who are hearing or visually
impaired and have special requirements, or a condition that requires
special assistance, should provide the information upon registering for
the meeting. The deadline for registration is listed in the DATES
section of this notice.
VI. Collection of Information Requirements
This document does not impose information collection and
recordkeeping requirements. Consequently, it need not be reviewed by
the Office of Management and Budget under the authority of the
Paperwork Reduction Act of 1995 (44 U.S.C. 35).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
[[Page 24019]]
Dated: May 14, 2009.
Charlene Frizzera,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. E9-12030 Filed 5-21-09; 8:45 am]
BILLING CODE 4120-01-P